<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-22T19:13:04Z</responseDate><request verb="GetRecord" identifier="oai:uwspace.uwaterloo.ca:10012/22741" metadataPrefix="dim">https://dspacemainprd01.lib.uwaterloo.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:uwspace.uwaterloo.ca:10012/22741</identifier><datestamp>2026-01-20T08:03:32Z</datestamp><setSpec>com_10012_9936</setSpec><setSpec>com_10012_1</setSpec><setSpec>col_10012_9941</setSpec><setSpec>col_10012_6</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="author">Kim, Gyeongsu</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2025-12-16T15:05:26Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2025-12-16T15:05:26Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2025-12-16</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="submitted">2025-12-09</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://hdl.handle.net/10012/22741</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract">Turnercyclamycins (TCMs) are a new family of cyclic lipopeptide antibiotics (cLPAs) isolated from Teredinibacter turnerae, a symbiont of shipworms. They contain thirteen amino acids, eight of which are contained in a macrocycle closed by an ester bond. Attached to the macrocycle is a linear pentapeptide that is lipidated at the N-terminus. The four members of this family, TCM A to D, only differ from one another in their lipid tail composition. Seven of the thirteen amino acids are non-proteinogenic: D-ornithine, D-threo-β-hydroxyaspartic acid (D-t-HOAsp), D-threo-β-hydroxydiaminobutyric acid (D-t-HODab), L-β-hydroxyisoleucine (L-HOIle), two D-allo-isoleucines (D-allo-Ile) and L-homoserine (L-hSer). Their mechanism of action (MoA) is unknown. The TCMs exhibit good activity against Gram-negative pathogens Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii (A. baumannii) including colistin-resistant A. baumannii suggesting that the TCMs act by a MoA that is different from colistin. These findings and the favourable pharmacokinetic properties displayed by the TCMs suggest that they may be good leads for the development of a novel antibiotic for treating colistin-resistant A. baumannii via a unique MoA. The total chemical synthesis of the TCMs has not been achieved and the configuration at the -carbon of L-HOIle is unknown. Here, our efforts to develop a total chemical synthesis of one of the TCMs, TCM C, which has a dodecanoyl fatty acyl tail, are described. These efforts began with the synthesis of D-t-HOAsp, D-t-HODab, and both stereoisomers of L-HOIle, suitably protected for Fmoc solid phase peptide synthesis (SPPS) using both literature and novel routes. Before synthesizing TCM C, an analogue of TCM C, called TCM C-CA, in which we substituted D-t-HODab for D-Dab, D-t-HOAsp for D-Asp and L-HOIle for L-Ile was prepared. This was achieved using Fmoc SPPS in an overall 5% yield. This synthesis provided valuable information on how to best perform some of the key steps such as ester bond formation and macrocycle formation without using up the valuable non-canonical amino acids prepared by chemical synthesis. The synthesis of two versions of TCM C, each one containing one of the two stereoisomers of L-HO-Ile, is in progress.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en</dim:field>
   <dim:field mdschema="dc" element="publisher" lang="en">University of Waterloo</dim:field>
   <dim:field mdschema="dc" element="title">Total Synthesis and Stereochemical Assignment of Turnercyclamycin C</dim:field>
   <dim:field mdschema="dc" element="type">Master Thesis</dim:field>
   <dim:field mdschema="dc" element="pending">false</dim:field>
   <dim:field mdschema="uws-etd" element="degree" qualifier="department">Chemistry</dim:field>
   <dim:field mdschema="uws-etd" element="degree" qualifier="discipline">Chemistry</dim:field>
   <dim:field mdschema="uws-etd" element="degree" qualifier="grantor" lang="en">University of Waterloo</dim:field>
   <dim:field mdschema="uws-etd" element="degree">Master of Science</dim:field>
   <dim:field mdschema="uws-etd" element="embargo" qualifier="terms">2 years</dim:field>
   <dim:field mdschema="uws" element="contributor" qualifier="advisor">Taylor, Scott</dim:field>
   <dim:field mdschema="uws" element="contributor" qualifier="affiliation1">Faculty of Science</dim:field>
   <dim:field mdschema="uws" element="published" qualifier="city" lang="en">Waterloo</dim:field>
   <dim:field mdschema="uws" element="published" qualifier="country" lang="en">Canada</dim:field>
   <dim:field mdschema="uws" element="published" qualifier="province" lang="en">Ontario</dim:field>
   <dim:field mdschema="uws" element="typeOfResource" lang="en">Text</dim:field>
   <dim:field mdschema="uws" element="peerReviewStatus" lang="en">Unreviewed</dim:field>
   <dim:field mdschema="uws" element="scholarLevel" lang="en">Graduate</dim:field>
   <dim:field mdschema="others" element="access-status">embargo</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>